Literature DB >> 25370592

Non-pharmacological management of problematic sleeping in children with developmental disabilities.

Karen Spruyt1, Leopold M G Curfs.   

Abstract

AIM: Sleep is important for underlying neural plasticity, and children with developmental disabilities suffer behavioural, emotional, cognitive, and sensory-motor issues that affect their wake and sleep states. Problematic sleeping can be hypothesized to have adverse effects on both of these areas in children with developmental disabilities. With this review, we aim to provide a benchmark in managing problematic sleeping in children with developmental disabilities.
METHOD: A literature search was conducted and data on the study descriptives, patient characteristics, study design, study-related factors, criteria applied to operationalize sleep and developmental disability, and sleep 'management' were collected. Each management strategy was tabulated and analysed.
RESULTS: We identified 90 studies involving 1460 children with developmental disabilities, of whom 61.6% were male. The highest proportion of studies, almost half, were in children with syndromes (44.4%), followed by studies in children with intellectual disabilities (18.9%). Non-pharmacological sleep management was primarily aimed at improving sleep quality (86.7%), followed by sleep-wake schedules and, to a certain extent, sleep regularity (42.2%). About 56.7% of the studies reported more than one approach. Studies mostly focused on disorders of initiating and maintaining sleep through a diversity of strategies and relied heavily on subjective measures to identify and monitor problematic sleeping. Sleep management approaches were primarily delivered at the level of the individual in the home setting. The number of management approaches per study was unrelated to the number of sleep problems discussed.
INTERPRETATION: Modifying sleep management strategies to meet the specific needs of children with developmental disabilities is encouraged, and studies that look beyond sleep quality or sleep quantity are required. It is also advocated that modifications to sleep hygiene, sleep regularity, and sleep ecology in a population with developmental disabilities are rigorously investigated. Finally, daytime somnolence should not be overlooked when aiming to optimize sleep in children with developmental disabilities across the ages and stages of their lives. There were several limitations in the research findings of problematic sleep in children with developmental disabilities. In general, the sleep problems and the developmental disabilities investigated were multicomponent in nature. It is likely that management approaches impacted those problems on multiple levels or through diverse 'therapeutic' pathways. There is a need for randomized controlled trials and more objective measures that quantify improved sleep or wake states.
© 2014 Mac Keith Press.

Entities:  

Mesh:

Year:  2014        PMID: 25370592     DOI: 10.1111/dmcn.12623

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  4 in total

1.  The Blind Men and the Elephant: The Risk of Misdiagnosis in Children with Developmental Disabilities.

Authors:  Karen Spruyt; Jian-Sheng Lin
Journal:  CNS Neurosci Ther       Date:  2016-11       Impact factor: 5.243

2.  Function-Based Behavioral Interventions for Sleep Problems in Children and Adolescents with Autism: Summary of 41 Clinical Cases.

Authors:  Laurie McLay; Karyn France; Neville Blampied; Jenna van Deurs; Jolene Hunter; Jacqui Knight; Brent Hastie; Amarie Carnett; Emma Woodford; Rosina Gibbs; Russell Lang
Journal:  J Autism Dev Disord       Date:  2021-02

3.  Environmental enrichment intervention for Rett syndrome: an individually randomised stepped wedge trial.

Authors:  Jenny Downs; Jenny Rodger; Chen Li; Xuesong Tan; Nan Hu; Kingsley Wong; Nicholas de Klerk; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2018-01-10       Impact factor: 4.123

4.  Sleep and Phelan-McDermid Syndrome: Lessons from the International Registry and the scientific literature.

Authors:  Bridgette A Moffitt; Sara M Sarasua; Linda Ward; Diana Ivankovic; Kathleen Valentine; Curtis Rogers; Katy Phelan; Luigi Boccuto
Journal:  Mol Genet Genomic Med       Date:  2022-08-23       Impact factor: 2.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.